Navis Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$979K Sell
816
-13
-2% -$13.3K 0.37% 56
2026
Q1
$762K Buy
829
+53
+7% +$53.7K 0.39% 69
2025
Q4
$833K Buy
776
+37
+5% +$35.4K 0.35% 60
2025
Q3
$564K Sell
739
-341
-32% -$254K 0.42% 51
2025
Q2
$842K Buy
1,080
+7
+0.7% +$5.44K 0.71% 30
2025
Q1
$886K Hold
1,073
0.87% 23
2024
Q4
$828K Hold
1,073
0.9% 24
2024
Q3
$950K Hold
1,073
1.03% 19
2024
Q2
$971K Hold
1,073
1.11% 17
2024
Q1
$834K Buy
1,073
+1
+0.1% +$712 1% 17
2023
Q4
$625K Hold
1,072
0.82% 28
2023
Q3
$576K Hold
1,072
0.83% 25
2023
Q2
$503K Buy
1,072
+1
+0.1% +$419 0.46% 36
2023
Q1
$368K Buy
1,071
+1
+0.1% +$337 0.4% 45
2022
Q4
$392K Hold
1,070
0.56% 38
2022
Q3
$346K Hold
1,070
0.53% 40
2022
Q2
$347K Buy
1,070
+335
+46% +$101K 0.37% 60
2022
Q1
$210K Hold
735
0.19% 99
2021
Q4
$203K Buy
+735
New +$186K 0.17% 100
2021
Q1
Sell
-735
Closed -$124K 154
2020
Q4
$124K Buy
+735
New +$110K 0.11% 105

Other funds holding LLY

Navis Wealth Advisors's LLY Position: Q2 2026 in Review

Navis Wealth Advisors reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $13.3K and leaving 816 shares worth $979K. The position accounts for 0.37% of the portfolio, ranked #56.

Navis Wealth Advisors first reported a position in LLY in Q4 2020 and has held it in 20 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Navis Wealth Advisors held 816 shares of Eli Lilly worth $979K as of Q2 2026.
  • Navis Wealth Advisors sold 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
  • Eli Lilly made up 0.37% of Navis Wealth Advisors's portfolio in Q2 2026, its #56 holding.
  • Navis Wealth Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 20 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Navis Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.